CRUK announces 2023 Manifesto for Cancer Research and Care
Cancer Research UK recently presented their “Cancer in the UK: Overview report 2023” and with that launched it’s Manifesto for Cancer Research and Care. It sets out a vision that aligns with our new 5 year strategic plan concentrating on impactful research, awareness campaigns to increase prevention and early detection, increased collaboration to improve cancer care and patient quality of life and survivorship.
The manifesto can be divided into four chapters, covering areas such as research, prevention, early detection, and treatment of cancer. The proposal calls for increased investment in research, prevention and early detection measures, and improvements in cancer care and patient outcomes.
The manifesto highlights the importance of research in preventing, detecting, and treating cancer. It emphasizes the need to translate discoveries into new technologies and treatments, securing rapid access to data, and making necessary reforms for the UK to remain an attractive destination for major oncology trials.
Regarding cancer prevention, the manifesto focuses on the importance of addressing social factors such as smoking, childhood obesity, alcohol, air pollution, and HPV. Currently, in the UK, smoking and excess bodyweight are the two leading causes of cancer. The proposal calls for bold action to reduce the chance of developing cancer, which would lessen the pressure on the NHS, save lives, and boost the economy.
It also emphasizes the importance of early detection and diagnosis of cancer, along with innovative pathways and models for access and care. The proposal calls for the optimization of screening programs, encouragement of help-seeking for signs and symptoms of cancer, and reduction of disparities in treatment and emergency care.
Finally, the manifesto stresses the need for investment and reform in England’s health services: to upskill the workforce, improve data infrastructure, and implement a national strategy with accountability and targets to drive improvements in cancer prevention and survival outcomes. The proposal calls for the UK Government to address workforce shortages, harness the power of data, and implement a national strategy to make the vision for cancer prevention and survival a reality.
Overall, the Cancer Research UK 2023 Manifesto aims to create a vision for cancer prevention and survival in the UK and drive improvements in cancer outcomes. The proposal calls for a coordinated effort from policymakers, healthcare providers, and researchers to tackle cancer and improve patient outcomes.
During CRUK’s presentation we were able to identify trends that had were in line with the recently published patient survey by the Head and Neck Cancers Coalition.
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…
Theatre Meets Healthcare: Breaking Barriers in Cancer Conversations
In Leicester, theatre is transforming how Black communities talk about cancer. Oracle Head & Neck Cancer UK, alongside Theatre Sans Frontières, is using interactive Forum Theatre to tackle stigma, improve healthcare conversations, and break down cultural barriers. Actors bring real-life cancer diagnosis experiences to the stage – but the audience isn’t just watching. They step in, suggest changes, and…
Jamie Theakston Announces He is Cancer-Free After Laryngeal Cancer Treatment
Heart Breakfast’s much-loved presenter, Jamie Theakston, has shared the incredible news that he is now cancer free! After completing treatment for stage one laryngeal cancer – cancer of the voice box (larynx), Jamie made his highly anticipated return to the airwaves today, reuniting with listeners and co-hosts alike. Diagnosed in September 2024, Jamie initially thought…
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.